Bruker Corporation (BRKR)
Market Cap | 10.67B |
Revenue (ttm) | 2.53B |
Net Income (ttm) | 296.60M |
Shares Out | 146.73M |
EPS (ttm) | 1.99 |
PE Ratio | 36.55 |
Forward PE | 26.11 |
Dividend | $0.20 (0.28%) |
Ex-Dividend Date | Feb 28, 2023 |
Volume | 677,436 |
Open | 72.69 |
Previous Close | 72.18 |
Day's Range | 72.00 - 73.42 |
52-Week Range | 48.42 - 76.81 |
Beta | 1.14 |
Analysts | Buy |
Price Target | 81.03 (+11.4%) |
Earnings Date | May 3, 2023 |
About BRKR
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain... [Read more]
Financial Performance
In 2022, Bruker's revenue was $2.53 billion, an increase of 4.67% compared to the previous year's $2.42 billion. Earnings were $296.60 million, an increase of 7.04%.
Financial StatementsAnalyst Forecast
According to 17 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price forecast is $81.03, which is an increase of 11.40% from the latest price.
News

Bruker (BRKR) Receives 1.2 GHz NMR System Orders From the UK
Bruker (BRKR) extends support to the expansion efforts of the UK Science community by providing 1.2 GHz Avance NMR spectrometers.

Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK
COVENTRY, United Kingdom--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker announces that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance™ nucl...

Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization
CHICAGO--(BUSINESS WIRE)---- $BRKR #BRKR--At the 19th US HUPO, Bruker Corporation (Nasdaq: BRKR) announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo ...

Bruker Corporation to Present at Investor Conferences
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the fol...

Bruker Announces Quarterly Dividend
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.0...

Bruker (BRKR) Q4 Earnings Beat Estimates, Margins Increase
Robust performance across most of the geographies and operating segments drove Bruker's (BRKR) Q4 revenues.

Bruker (BRKR) Surpasses Q4 Earnings and Revenue Estimates
Bruker (BRKR) delivered earnings and revenue surprises of 2.78% and 5.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the fiscal year ended December 31, 2022. Fourth Qu...

Why Earnings Season Could Be Great for Bruker (BRKR)
Bruker (BRKR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Top 5 Large-Cap Stocks Set to Beat on Q4 Earnings This Week
Five large-cap companies are set to beat fourth-quarter earnings estimates this week. These are: PRU, OMC, YUM, SLF, and BRKR.

Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology
FÄLLANDEN, Switzerland--(BUSINESS WIRE)--Bruker today announced successful customer installations of two novel, compact 1.0 GHz NMR spectrometers for advanced structural and molecular biology applic...

Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Bruker (BRKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2022 financial results before market opening on Thursday, February ...

Bruker Announces Acquisition of ACQUIFER Imaging GmbH
HEIDELBERG, Germany--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-c...

Bruker's (BRKR) New Tie-Up to Expand Its U.S. CRO Business
Bruker's (BRKR) latest partnership is expected to expand its CRO business in the United States, benefiting more biopharma and diagnostics companies using unbiased proteomics for decision-making.

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
BILLERICA, Mass. & SCHLIEREN, Switzerland--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) and Switzerland-based Biognosys AG today announced a strategic partnership, in which Bruker has made a m...

Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 41st annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairma...

Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies
HANAU, Germany & BERGISCH GLADBACH, Germany & CARTERET, N.J.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced that its Bruker Energy & Supercon Technologies (BEST) division, and majorit...

Functional precision oncology leader Kiyatec announces Series C round with US$18 million closing to accelerate adoption of transformational cancer platform
GREENVILLE S.C.--(BUSINESS WIRE)--Kiyatec Inc. announced today a closing of its Series C funding round totaling US$18 million from new and existing investors. New investor Bruker (Nasdaq: BRKR) led ...

Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provide...

Bruker (BRKR) Q3 Earnings Beat Estimates, '22 Sales View Down
Despite ongoing macroeconomic headwinds, Bruker (BRKR) registers strong demand for differentiated high-value scientific instruments and life science solutions.

Bruker Announces Acquisition of Inscopix for Neuroscience Research
MOUNTAIN VIEW, Calif.

Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference
BILLERICA, Mass.

Bruker (BRKR) Q3 Earnings and Revenues Surpass Estimates
Bruker (BRKR) delivered earnings and revenue surprises of 24.53% and 4.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?